Hawaiian Telcom Holdco, Inc. (HCOM) Forms $26.81 Double Bottom; Chiasma (CHMA) Shorts Down By 8.24%

June 13, 2018 - By olga

Hawaiian Telcom Holdco, Inc. (NASDAQ:HCOM) Logo

Chiasma Inc (NASDAQ:CHMA) had a decrease of 8.24% in short interest. CHMA’s SI was 133,700 shares in June as released by FINRA. Its down 8.24% from 145,700 shares previously. With 15,000 avg volume, 9 days are for Chiasma Inc (NASDAQ:CHMA)’s short sellers to cover CHMA’s short positions. The SI to Chiasma Inc’s float is 1.15%. The stock increased 1.72% or $0.02 during the last trading session, reaching $1.5. About 435 shares traded. Chiasma, Inc. (NASDAQ:CHMA) has risen 3.33% since June 13, 2017 and is uptrending. It has underperformed by 9.24% the S&P500. Some Historical CHMA News: ; 14/05/2018 – CHIASMA INC – FDA INDICATED IT PLANS TO CONSIDER SECONDARY ENDPOINTS IN ITS EVALUATION OF TOTALITY OF EVIDENCE OF ORAL OCTREOTIDE’S TREATMENT EFFECT; 14/05/2018 – Chiasma Announces FDA Agreement to Redefine Certain Secondary Endpoints in CHIASMA OPTIMAL Phase 3 Clinical Trial; 20/03/2018 – CHIASMA INC – EXPECTS TO HAVE A CASH AND INVESTMENT BALANCE OF AT LEAST $35 MLN AT END OF 2018; 16/03/2018 Chiasma Announces Poster Presentation at ENDO 2018 on Study Design of Phase 3 Double-Blind Trial Evaluating Oral Octreotide Cap; 14/05/2018 – CHIASMA INC – UNDER SPA AGREEMENT MODIFICATION FOR CHIASMA OPTIMAL PHASE 3 TRIAL, BETWEEN-ARM COMPARISONS OF 2 DESCRIPTIVE MEASURES WILL NOT BE MADE; 10/05/2018 – CHIASMA – EXPECTS EXISTING CASH, INVESTMENTS WILL BE SUFFICIENT TO FUND OPS THROUGH ANTICIPATED RELEASE OF DATA FROM CHIASMA OPTIMAL TRIAL BY 2019 END; 14/05/2018 – CHIASMA – FOURTH, FIFTH SECONDARY ENDPOINTS IN PHASE 3 TRIAL NOW BEEN REDEFINED TO DESCRIPTIVE STATISTICS MEASURED WITHIN EACH TREATMENT GROUP; 10/05/2018 – Chiasma 1Q Loss/Shr 29c; 15/05/2018 – Point72 Asset Management Buys New 3.3% Position in Chiasma; 20/03/2018 – Chiasma 4Q Loss/Shr 25c

Hawaiian Telcom Holdco, Inc. (HCOM) formed double bottom with $24.67 target or 8.00% below today’s $26.81 share price. Hawaiian Telcom Holdco, Inc. (HCOM) has $312.80 million valuation. The stock decreased 0.22% or $0.06 during the last trading session, reaching $26.81. About 23,400 shares traded or 34.11% up from the average. Hawaiian Telcom Holdco, Inc. (NASDAQ:HCOM) has risen 8.01% since June 13, 2017 and is uptrending. It has underperformed by 4.56% the S&P500. Some Historical HCOM News: ; 12/03/2018 – VP Komeiji Disposes 266 Of Hawaiian Telcom Holdco Inc; 13/03/2018 – HAWAIIAN TELCOM HOLDCO INC – FULL YEAR NET LOSS OF $107.2 MLN WAS PRIMARILY DUE TO AN $88.0 MLN INCOME TAX PROVISION; 09/05/2018 – CINCINNATI BELL INC – 2018 GUIDANCE DOES NOT INCLUDE ANY CONTRIBUTION FROM PENDING MERGER WITH HAWAIIAN TELCOM; 13/03/2018 – HAWAIIAN TELCOM HOLDCO – REGULATORY REVIEW PROCESSES FOR MERGER WITH CINCINNATI BELL “WELL UNDERWAY”; 19/04/2018 – DJ Hawaiian Telcom Holdco Inc, Inst Holders, 1Q 2018 (HCOM); 04/05/2018 – Cincinnati Bell-Hawaiian Telcom Merger Receives Hawai’i PUC Approval; 04/05/2018 – CINCINNATI BELL-HAWAIIAN TELCOM DEAL GETS HAWAII PUC APPROVAL; 04/05/2018 – Cincinnati Bell-Hawaiian Telcom Merger Receives Hawai I PUC Approval; 26/04/2018 – Hawaiian Telcom Announces Earnings Release Date for First Quarter 2018; 13/03/2018 – HAWAIIAN TELCOM HOLDCO INC – FOURTH QUARTE CONSUMER STRATEGIC REVENUE GROWTH OF 2 PERCENT

Among 3 analysts covering Chiasma (NASDAQ:CHMA), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. Chiasma had 6 analyst reports since August 10, 2015 according to SRatingsIntel. The firm earned “Market Perform” rating on Monday, April 18 by William Blair. Barclays Capital downgraded the shares of CHMA in report on Monday, April 25 to “Equal-Weight” rating. Barclays Capital initiated Chiasma, Inc. (NASDAQ:CHMA) on Monday, August 10 with “Overweight” rating. Barclays Capital downgraded Chiasma, Inc. (NASDAQ:CHMA) on Tuesday, January 17 to “Underweight” rating. The rating was initiated by Cowen & Co on Monday, August 10 with “Outperform”. William Blair initiated the shares of CHMA in report on Monday, August 10 with “Outperform” rating.

Chiasma, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing oral forms of therapies using transient permeability enhancer technology platform. The company has market cap of $36.58 million. The firm offers octreotide capsules, which is in Phase III clinical trial for the treatment of acromegaly, a condition that results in the bodyÂ’s production of excess growth hormone under the MYCAPSSA name. It currently has negative earnings.

Investors sentiment decreased to 0.72 in Q1 2018. Its down 0.56, from 1.28 in 2017Q4. It fall, as 7 investors sold Hawaiian Telcom Holdco, Inc. shares while 25 reduced holdings. 8 funds opened positions while 15 raised stakes. 7.88 million shares or 1.74% more from 7.75 million shares in 2017Q4 were reported. Blackrock holds 295,263 shares. 35,701 were reported by D E Shaw &. Legal & General Gru Public Ltd Co stated it has 0% in Hawaiian Telcom Holdco, Inc. (NASDAQ:HCOM). Gam Holdings Ag holds 233,021 shares. Loomis Sayles Com L P invested in 546,273 shares or 0.03% of the stock. The New York-based State Bank Of New York Mellon Corporation has invested 0% in Hawaiian Telcom Holdco, Inc. (NASDAQ:HCOM). Stevens Capital Mgmt Lp stated it has 0.02% in Hawaiian Telcom Holdco, Inc. (NASDAQ:HCOM). Nomura Hldgs holds 455,666 shares or 0.01% of its portfolio. Polar Asset Prtnrs invested in 75,000 shares. Strs Ohio holds 0% or 21,200 shares. Private Grp accumulated 436,427 shares. Nelson Roberts Inv Advisors Lc holds 0% or 148 shares. Parametric Port Assoc Ltd stated it has 0% in Hawaiian Telcom Holdco, Inc. (NASDAQ:HCOM). Schwab Charles Investment Management holds 0% or 13,702 shares. American Intl Gru Inc has invested 0% of its portfolio in Hawaiian Telcom Holdco, Inc. (NASDAQ:HCOM).

Hawaiian Telcom Holdco, Inc. (NASDAQ:HCOM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>